[no subject]

["Dr. Usha Gupta" <usha_gupta2@yahoo.com>]

Response to Pooled pharmaceutical procurement
Sender: owner-india-drug@usa.healthnet.org
Precedence: bulk
Reply-To: india-drug@usa.healthnet.org

Response to Pooled pharmaceutical procurement
-----------------------------------------------


Dar I drug participants,

The experience gained at Delhi and Tamilnadu clearly indicates that 
pooled procurement has many advantages. It reduces the cost of
medicines and increases the availablilty of essential madicines (EM) in
health facilities and hospitals. Another added advantage of central
procurement, which has been noticed, relates to minimising chances of
corruption at multiple levels of procurement in case of decentralised
procurement.

However, Central Pool Procurement must be at the state level and NOT at
Country level which is unmanagable in a vast country like ours.
It is also important that selection of EM in each hospital and health 
facility should be streamlined, although the selection is being made 
from Esssential Medicines List of the state only. It should strictly be
need based as per level of health facility.

Decentralizing selection & procurement of EM at Zila Parshid and 
Panchayat level may worsen the situation.

Dr. Usha Gupta
DSPRUD


________________________________________________________________________
Yahoo! India Matrimony: Find your partner online. http://yahoo.shaadi.com/india-matrimony/

Access Essential Drugs Monitor #32 at http://www.who.int/medicines/mon/mon32.shtml

The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@healthnet.org
To subscribe or unsubscribe, write to: majordomo@healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@healthnet.org